CN Stock MarketDetailed Quotes
000930 Cofco Biotechnology
- 5.99
- -0.17-2.76%
Market Closed Dec 13 15:00 CST
11.14BMarket Cap-43.09P/E (TTM)
6.15High5.96Low370.88KlotVolume6.15Open6.16Pre Close223.32MTurnover2.00%Turnover RatioLossP/E (Static)1.86BShares6.8052wk High1.06P/B11.12BFloat Cap4.4252wk Low6.78Limit Up1.86BShs Float28.28Historical High5.54Limit Down3.08%Amplitude0.80Historical Low--Dividend TTM6.02Avg Price200.03KlotAsk--Div YieldTTM100Lot Size169.30KlotBid
Cofco Biotechnology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -3.61%16.72B | -0.60%11.3B | 1.45%5.75B | 4.28%24.2B | -0.84%17.35B | -6.22%11.37B | -5.69%5.66B | -10.09%23.21B | -10.57%17.49B | -8.22%12.13B |
| Refunds of taxes and levies | -49.60%107.46M | -58.07%73.43M | -19.15%46.73M | -25.22%185.41M | 7.84%213.22M | 70.40%175.11M | 25.60%57.81M | 80.78%247.93M | 96.68%197.73M | 72.10%102.76M |
| Cash received relating to other operating activities | -16.20%393.08M | -53.11%252.97M | -81.32%136.82M | -30.91%563.06M | -76.59%469.05M | -76.49%539.5M | -8.10%732.53M | -9.69%814.91M | 37.84%2B | 305.77%2.3B |
| Cash inflows from operating activities | -4.48%17.22B | -3.78%11.63B | -8.13%5.93B | 2.80%24.95B | -8.46%18.03B | -16.79%12.09B | -5.76%6.45B | -9.61%24.27B | -6.72%19.7B | 4.96%14.53B |
| Goods services cash paid | 4.58%15.74B | -0.80%11.77B | -13.05%6.91B | -2.24%20.78B | -1.15%15.05B | -0.51%11.86B | 38.09%7.95B | 9.50%21.25B | 13.05%15.23B | 13.84%11.92B |
| Staff behalf paid | -7.30%661.5M | -1.36%448.34M | -15.56%213.7M | 4.98%969.74M | -0.33%713.6M | -11.91%454.53M | -11.12%253.08M | -9.06%923.74M | -3.67%715.97M | -2.61%515.96M |
| All taxes paid | -1.16%326.73M | -12.05%205.66M | -28.88%87.5M | -15.85%400.18M | -21.57%330.57M | 8.77%233.84M | 120.53%123.03M | -35.77%475.55M | -29.79%421.47M | -45.49%214.98M |
| Cash paid relating to other operating activities | -41.07%393.66M | -60.71%274.08M | -84.08%128.33M | -7.24%842.68M | -60.51%668.02M | -63.91%697.6M | -0.70%806.3M | 7.77%908.49M | 60.21%1.69B | 418.78%1.93B |
| Cash outflows from operating activities | 2.14%17.12B | -4.17%12.69B | -19.61%7.34B | -2.42%22.99B | -7.16%16.76B | -9.18%13.25B | 32.17%9.13B | 7.05%23.56B | 13.78%18.06B | 23.93%14.59B |
| Net cash flows from operating activities | -92.14%99.56M | 8.30%-1.06B | 47.24%-1.41B | 176.38%1.96B | -22.77%1.27B | -1,825.20%-1.16B | -4,118.60%-2.68B | -85.37%708.44M | -68.74%1.64B | -102.91%-60.22M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5.6M | -93.22%5.6M | ---- |
| Cash received from returns on investments | ---- | ---- | ---- | -40.24%5.49M | -96.82%292.26K | ---- | ---- | 474.22%9.19M | 474.22%9.19M | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -90.04%16.35M | 307.13%16.2M | 174.38%122.96K | -32.64%166.32M | 218.19%164.14M | -92.35%3.98M | -104.12%-165.31K | -8.68%246.92M | 212.05%51.59M | 219.81%52.02M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- | ---- | ---- |
| Cash received relating to other investing activities | 9,963.21%774.87M | 4,683.70%378.06M | 80.99%8.5M | -75.38%8.9M | -73.37%7.7M | -86.11%7.9M | 176.94%4.7M | -46.71%36.14M | 8.02%28.91M | 220.43%56.91M |
| Cash inflows from investing activities | 359.66%791.21M | 3,218.30%394.25M | 90.31%8.62M | -39.33%180.71M | 80.65%172.13M | -89.09%11.88M | -20.59%4.53M | -40.47%297.84M | -25.24%95.28M | 220.14%108.93M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -36.43%311.85M | -42.79%192.5M | -43.45%130.44M | 12.15%634.52M | 30.99%490.57M | 21.28%336.48M | 10.88%230.65M | -49.02%565.78M | -48.66%374.51M | -46.16%277.45M |
| Cash paid relating to other investing activities | 3,758.34%712.72M | 2,860.35%452.65M | 2,939.57%158.88M | 265.13%119.18M | -61.15%18.47M | -70.08%15.29M | -82.90%5.23M | -44.15%32.64M | -16.73%47.55M | 37.71%51.1M |
| Cash outflows from investing activities | 101.28%1.02B | 83.40%645.15M | 22.66%289.32M | 25.95%753.7M | 20.61%509.04M | 7.07%351.77M | -1.13%235.88M | -48.77%598.42M | -46.35%422.06M | -40.53%328.54M |
| Net cash flows from investing activities | 30.74%-233.36M | 26.18%-250.9M | -21.33%-280.69M | -90.63%-572.99M | -3.10%-336.91M | -54.77%-339.89M | 0.66%-231.35M | 55.00%-300.58M | 50.43%-326.77M | 57.64%-219.61M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | 50.00%88.2M | --44.1M | --44.1M | --44.1M | --58.8M | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | 50.00%88.2M | --44.1M | --44.1M | --44.1M | --58.8M | ---- | ---- |
| Cash from borrowing | -14.51%5.37B | -20.63%4.62B | -24.91%2.74B | 17.52%7.56B | 47.06%6.28B | 48.82%5.82B | 88.89%3.65B | -22.00%6.44B | -19.85%4.27B | -18.13%3.91B |
| Cash inflows from financing activities | -15.11%5.37B | -21.22%4.62B | -25.80%2.74B | 17.82%7.65B | 48.10%6.32B | 49.95%5.87B | 91.17%3.69B | -21.29%6.5B | -19.74%4.27B | -18.13%3.91B |
| Borrowing repayment | -7.14%4.94B | 8.11%2.98B | 95.37%1.21B | 11.53%7.24B | 11.43%5.32B | -10.50%2.76B | -55.13%619.27M | -43.99%6.49B | -46.89%4.78B | -45.83%3.08B |
| Dividend interest payment | -94.08%73.08M | -91.24%46.85M | -22.03%20.18M | 121.69%1.25B | 129.33%1.24B | 4.56%534.66M | -13.98%25.89M | 104.08%566M | 104.41%538.65M | 218.11%511.36M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | 633.33%82.5M | --82.5M | ---- | --0 | --11.25M | ---- | ---- |
| Cash payments relating to other financing activities | 796.24%177.04M | 240.13%56.03M | -1.80%5.48M | 18.94%36.55M | 8.29%19.75M | 89.08%16.47M | -10.94%5.58M | -63.51%30.73M | 42.14%18.24M | -55.91%8.71M |
| Cash outflows from financing activities | -21.05%5.19B | -6.79%3.08B | 89.87%1.24B | 20.35%8.53B | 23.33%6.58B | -8.12%3.31B | -54.06%650.73M | -40.69%7.09B | -42.46%5.33B | -38.64%3.6B |
| Net cash flows from financing activities | 168.79%175.07M | -39.88%1.54B | -50.54%1.5B | -48.08%-880.04M | 76.08%-254.48M | 719.94%2.56B | 490.22%3.04B | 83.95%-594.28M | 73.07%-1.06B | 128.67%312.03M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 331.71%35.04M | -759.71%-26.96M | -6,008.05%-24.21M | -72.58%11.07M | -154.36%-15.12M | -73.10%4.09M | 182.87%409.74K | 1,034.01%40.37M | 925.26%27.82M | 477.43%15.19M |
| Net increase in cash and cash equivalents | -88.44%76.31M | -81.47%197.06M | -264.76%-214.77M | 453.32%516.02M | 138.02%660.22M | 2,143.86%1.06B | -40.36%130.36M | -131.23%-146.05M | -56.24%277.37M | -89.66%47.39M |
| Add:Begin period cash and cash equivalents | 53.58%1.48B | 53.58%1.48B | 45.64%1.48B | -13.17%963.02M | -13.19%963.02M | -13.17%963.02M | -8.49%1.02B | 72.92%1.11B | 70.75%1.11B | 72.92%1.11B |
| End period cash equivalent | -4.18%1.56B | -17.28%1.68B | 10.33%1.26B | 53.58%1.48B | 17.05%1.62B | 75.21%2.03B | -13.74%1.15B | -13.17%963.02M | 8.04%1.39B | 5.17%1.16B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
